G-Quadruplex-Mediated Transcriptional Regulation of PDGFR-??
G-四链体介导的 PDGFR-?? 转录调控
基本信息
- 批准号:8450187
- 负责人:
- 金额:$ 32.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdenineAffinity ChromatographyArteriosclerosisAspergillus Nuclease S1Base PairingBerylliumBindingBiologicalBiological AssayBiological ProcessDNAData ReportingDependencyDiseaseDoseElementsFeedbackFunctional disorderG-QuartetsGC Rich SequenceGene ExpressionGenesGenetic TranscriptionGoalsGuanineHousingHumanIndiumIndividualInflammatoryLibrariesLuciferasesMalignant NeoplasmsMalignant neoplasm of pancreasMapsMediatingMethodsMolecular TargetMusMutationNuclear ExtractPDGFRB genePatternPharmaceutical PreparationsPlasmidsPlatelet-Derived Growth Factor ReceptorPlatelet-Derived Growth Factor beta ReceptorPrimer ExtensionPromoter RegionsProteinsRelative (related person)ReporterReporter GenesRunningSequence DeletionSp1 Transcription FactorStructureSystemTechniquesTestingTherapeuticTimeTranscription Initiation SiteTranscriptional Regulationbasec-myc Genescombinatorialinsightmutantnucleaseoverexpressionprogramspromoterpublic health relevanceresearch studyscreeningsmall moleculestructural biologytelomestatintwo-dimensional
项目摘要
DESCRIPTION (provided by applicant): Overexpression of PDGFR-beta is an important factor in pancreatic cancer as well as other inflammatory diseases, including arteriosclerosis and therefore is a highly significant molecular target. The long-range goal of this proposal is to develop small molecule therapeutics that will specifically suppress PDGFR-beta gene expression. Our strategy takes advantage of the recent insight into the importance of G-quadruplexes in transcriptional silencing of a number of genes, including c-Myc. Preliminary data reported in this proposal demonstrate that a cluster of four overlapping G-quadruplexes are key elements in the control of PDGFR-beta transcription. We have also demonstrated that known G-quadruplex-interactive compounds have differential effects on PDGFR-beta gene expression dependent on the selectivity for the constituent G-quadruplexes. Transcriptionally induced superhelicity has been demonstrated to be important in the conversion of duplex DNA to G-quadruplex in promoter region. Thus our hypothesis to be tested is that the negative superhelicity induced by transcription provides a real-time feedback mechanism into the NHE in the PDGFR-beta promoter to modulate both the firing rate (cruise control) and activation or silencing (on/off switch) of PDGFR-beta transcription. The specific aims are: (1) To determine the biological function of the 54-end, mid-54, mid-34, and 34-end G-quadruplex-forming sequences by deletion and mutational analysis of the PDGFR-beta promoter element and then determine the effect of supercoiling on the pattern of G-quadruplex formation in the PDGFR-beta promoter. (2) To determine by NMR the folding patterns and structures of the G-quadruplexes in the PDGFR-beta promoter. (3) To identify specific proteins and small molecules that bind differentially to the constituent G-quadruplexes found in the PDGFR-beta promoter. For specific aim 1, we will construct supercoiled plasmids containing PDGFR-beta promoter inserts and a luciferase reporter system. For specific aim 2, high-field NMR will be used to determine the structures of the constituent G-quadruplexes located in the PDGFR-beta promoter element. For specific aim 3, we will use affinity chromatography and small molecule screening methods to identify proteins and drug-like molecules that bind to the individual G-quadruplexes. The biological effects of these entities will be determined in specific aim 1.
描述(由申请人提供):PDGFR-β的过表达是胰腺癌以及其他炎症性疾病(包括动脉硬化)的重要因素,因此是一个非常重要的分子靶标。该提案的远程目标是开发小分子疗法,这些疗法将特别抑制PDGFR-beta基因表达。我们的策略利用了最近对G四链体在包括C-Myc在内的许多基因转录沉默中的重要性的洞察力。该提案中报告的初步数据表明,四个重叠的G四链体的集群是控制PDGFR-Beta转录的关键要素。我们还证明,已知的G四链体相互作用化合物对pDGFR-beta基因表达具有不同的影响,取决于成分G-四链体的选择性。已证明转录诱导的超螺旋性在启动子区域的双链DNA转化为G-四链体中很重要。因此,我们要检验的假设是,转录引起的负超固有性为PDGFR-Beta启动子中的NHE提供了实时反馈机制,以调节PDGFR-BETA转录的发射速率(巡航控制)和激活或沉默(ON/OFF开关)。具体目的是:(1)通过缺失和PDGFR-BETA启动子元素的缺失和突变分析来确定54端,54,34中期和34端G Quadruplex形成序列的生物学功能,然后确定超涂层对G- Ququlexruplex构造在PDGGRERIN the PDGGREFREFRERERERERERIN in pDGGERERINIC inta PDGGRETA启动的效果。 (2)通过NMR确定pDGFR-beta启动子中G-四链体的折叠模式和结构。 (3)鉴定特定的蛋白质和小分子,它们与PDGFR-beta启动子中发现的成分G-四链体的结合。对于特定的目标1,我们将构建包含PDGFR-BETA启动子插入物和荧光素酶报告器系统的超螺旋质粒。对于特定目标2,将使用高场NMR来确定位于PDGFR-Beta启动子元件中的组成型G-四链体的结构。对于特定的目标3,我们将使用亲和色谱和小分子筛选方法来鉴定与单个G四链体结合的蛋白质和药物样分子。这些实体的生物学效应将在特定目标1中确定。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAURENCE H. HURLEY其他文献
LAURENCE H. HURLEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAURENCE H. HURLEY', 18)}}的其他基金
The Development of Novel Inhibitors of BCL2 Gene Expression as Anticancer Therape
开发新型 BCL2 基因表达抑制剂作为抗癌疗法
- 批准号:
8642980 - 财政年份:2014
- 资助金额:
$ 32.85万 - 项目类别:
G-Quadruplex-Mediated Transcriptional Regulation of PDGFR-??
G-四链体介导的 PDGFR-?? 转录调控
- 批准号:
8396719 - 财政年份:2010
- 资助金额:
$ 32.85万 - 项目类别:
G-Quadruplex-Mediated Transcriptional Regulation of PDGFR-??
G-四链体介导的 PDGFR-?? 转录调控
- 批准号:
8657680 - 财政年份:2010
- 资助金额:
$ 32.85万 - 项目类别:
G-Quadruplex-Mediated Transcriptional Regulation of PDGFR-??
G-四链体介导的 PDGFR-?? 转录调控
- 批准号:
8658028 - 财政年份:2010
- 资助金额:
$ 32.85万 - 项目类别:
G-Quadruplex-Mediated Transcriptional Regulation of PDGFR-??
G-四链体介导的 PDGFR-?? 转录调控
- 批准号:
8104001 - 财政年份:2010
- 资助金额:
$ 32.85万 - 项目类别:
G-Quadruplex-Mediated Transcriptional Regulation of PDGFR-??
G-四链体介导的 PDGFR-?? 转录调控
- 批准号:
8287242 - 财政年份:2010
- 资助金额:
$ 32.85万 - 项目类别:
G-Quadruplex-Mediated Transcriptional Regulation of PDGFR-??
G-四链体介导的 PDGFR-?? 转录调控
- 批准号:
8257544 - 财政年份:2010
- 资助金额:
$ 32.85万 - 项目类别:
Establishing a molecular system for drug targeting of transcriptional control
建立转录控制药物靶向分子系统
- 批准号:
7908381 - 财政年份:2009
- 资助金额:
$ 32.85万 - 项目类别:
Establishing a molecular system for drug targeting of transcriptional control
建立转录控制药物靶向分子系统
- 批准号:
8118451 - 财政年份:2008
- 资助金额:
$ 32.85万 - 项目类别:
相似国自然基金
基于亲和导向-邻近反应的复杂体系天然蛋白固定新方法及色谱评价
- 批准号:22374116
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于亲和色谱策略筛选和挖掘磷酸酶PP2A新型调节剂
- 批准号:22377149
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于仿生亲和色谱-质谱策略的肺结核患者血清抗体谱研究
- 批准号:82160027
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于亲和色谱靶点“钩钓”策略研究补肾活血方抗AGEs诱导神经损伤的作用机制
- 批准号:82104621
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
固定化单构象态受体亲和色谱的建立及止喘灵方平喘功效物质研究
- 批准号:82174088
- 批准年份:2021
- 资助金额:55.00 万元
- 项目类别:面上项目
相似海外基金
G-Quadruplex-Mediated Transcriptional Regulation of PDGFR-??
G-四链体介导的 PDGFR-?? 转录调控
- 批准号:
8396719 - 财政年份:2010
- 资助金额:
$ 32.85万 - 项目类别:
G-Quadruplex-Mediated Transcriptional Regulation of PDGFR-??
G-四链体介导的 PDGFR-?? 转录调控
- 批准号:
8657680 - 财政年份:2010
- 资助金额:
$ 32.85万 - 项目类别:
G-Quadruplex-Mediated Transcriptional Regulation of PDGFR-??
G-四链体介导的 PDGFR-?? 转录调控
- 批准号:
8658028 - 财政年份:2010
- 资助金额:
$ 32.85万 - 项目类别:
G-Quadruplex-Mediated Transcriptional Regulation of PDGFR-??
G-四链体介导的 PDGFR-?? 转录调控
- 批准号:
8104001 - 财政年份:2010
- 资助金额:
$ 32.85万 - 项目类别:
G-Quadruplex-Mediated Transcriptional Regulation of PDGFR-??
G-四链体介导的 PDGFR-?? 转录调控
- 批准号:
8287242 - 财政年份:2010
- 资助金额:
$ 32.85万 - 项目类别: